Journal rankings · indicator year 2008
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2008
Pharmacology, Toxicology and Pharmaceutics journal rankings 2008
40 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 40 ranked journals in 2008. The median OJR fell 0.16 on 2007 to 0.95, below the world average of 1.00; Q1 starts at OJR 1.65. The top three are The Pharmacogenomics Journal, Current Drug Metabolism, and Pharmacogenetics and Genomics.
Ranks and citation indicators: 2008. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2005–2007, the window the 2008 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences40 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2007. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2005–2007, the window the 2008 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2005–2007 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2008. | Compare |
|---|---|---|---|---|---|---|---|
1The Pharmacogenomics JournalSpringer Nature · United Kingdom | 2.79Q1 | 5.84 1.17 up from 2007 | 181 | 27% | $4,890 | ||
2Current Drug MetabolismBentham Science Publishers · Netherlands | 2.66Q1 | 4.76 0.11 down from 2007 | 180 | 7% | — | ||
3Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 2.47Q1 | 5.25 0.47 down from 2007 | 321 | 25% | — | ||
4Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 2.10Q1 | 3.85 1.13 up from 2007 | 38 | 5% | — | ||
5Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.96Q1 | 3.52 0.25 up from 2007 | 215 | 10% | — | ||
6Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.87Q1 | 3.99 0.45 up from 2007 | 855 | 22% | $3,500 | ||
7Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.85Q1 | 4.07 0.41 up from 2007 | 893 | 29% | $4,690 | ||
8European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 1.75Q1 | 2.89 0.47 up from 2007 | 612 | 10% | $4,210 | ||
9Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 1.67Q1 | 3.83 0.47 up from 2007 | 201 | 4% | — | ||
10Current Drug DeliveryBentham Science Publishers · Netherlands | 1.65Q1 | 3.18 0.28 up from 2007 | 125 | 2% | — | ||
11PharmacogenomicsFuture Medicine · United Kingdom | 1.61Q2 | 3.76 0.35 up from 2007 | 385 | 10% | — | ||
12Drug Metabolism and PharmacokineticsElsevier BV · Japan | 1.60Q2 | 3.06 0.22 up from 2007 | 179 | 5% | $3,580 | ||
13European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.58Q2 | 2.75 0.27 down from 2007 | 529 | 3% | $3,070 | ||
14International Journal of PharmaceuticsElsevier BV · Netherlands | 1.54Q2 | 2.82 0.30 up from 2007 | 1,826 | 8% | $4,650 | ||
15Drug SafetyAdis, Springer Healthcare · New Zealand | 1.44Q2 | 2.10 0.46 down from 2007 | 518 | 0% | $4,990 | ||
16Expert Opinion on Drug SafetyTaylor & Francis · United Kingdom | 1.38Q2 | 2.91 0.02 down from 2007 | 248 | 2% | — | ||
17AAPS PharmSciTechSpringer Science+Business Media · United States | 1.21Q2 | 1.70 0.13 down from 2007 | 300 | 100% | $4,190 | ||
18Journal of MicroencapsulationTaylor & Francis · United Kingdom | 1.05Q2 | 1.64 0.09 up from 2007 | 212 | 4% | — | ||
19XenobioticaTaylor & Francis · United Kingdom | 1.05Q2 | 2.03 0.02 down from 2007 | 252 | 7% | — | ||
20Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.05Q2 | 2.04 0.64 down from 2007 | 334 | 35% | $4,823 | ||
21Drug DeliveryOATaylor & Francis · United Kingdom | 0.85Q3 | 1.44 0.15 down from 2007 | 163 | 98% | $2,864 | ||
22Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.80Q3 | 1.62 0.27 up from 2007 | 690 | 8% | $3,660 | ||
23Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.72Q3 | 1.23 0.15 up from 2007 | 406 | 5% | — | ||
24Biopharmaceutics & Drug DispositionWiley · United Kingdom | 0.70Q3 | 1.61 0.11 up from 2007 | 160 | 4% | $3,800 | ||
25Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.69Q3 | 1.72 0.14 up from 2007 | 204 | 9% | — | ||
26Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.65Q3 | 1.23 0.29 up from 2007 | 217 | 3% | — | ||
27Dissolution TechnologiesUnited States | 0.65Q3 | 0.81 0.32 up from 2007 | 73 | 81% | — | ||
28American Journal of Drug DeliverySpringer Science+Business Media · New Zealand | 0.56Q3 | 1.44 0.44 up from 2007 | 45 | — | — | ||
29Current Chemical BiologyBentham Science Publishers · Netherlands | 0.56Q3 | 1.11no 2007 value | 54 | 2% | — | — | |
30Current Drug TherapyBentham Science Publishers · Netherlands | 0.37Q3 | 0.71 0.26 up from 2007 | 59 | 5% | — | ||
31Drug metabolism and drug interactionsDe Gruyter · Germany | 0.35Q4 | 0.82 0.32 up from 2007 | 34 | 4% | — | ||
32YAKUGAKU ZASSHIOAPharmaceutical Society of Japan · Japan | 0.34Q4 | 0.66 0.11 down from 2007 | 533 | 88% | — | ||
33Journal of Drug Delivery Science and TechnologyElsevier BV · France | 0.34Q4 | 0.60 0.05 down from 2007 | 204 | 5% | $3,810 | ||
34Forensic ToxicologySpringer Science+Business Media · Japan | 0.33Q4 | 0.67 0.04 up from 2007 | 36 | 0% | $2,990 | ||
35Drug Metabolism LettersBentham Science Publishers · Netherlands | 0.32Q4 | 0.52no 2007 value | 52 | 8% | — | — | |
36European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.22Q4 | 0.52 0.04 down from 2007 | 112 | 0% | $2,690 | ||
37Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 0.13Q4 | 0.17 0.10 down from 2007 | 50 | 100% | $1,207 | ||
38Journal of Pharmaceutical Marketing & ManagementHaworth Press · United States | 0.12Q4 | 0.03 0.02 down from 2007 | 63 | 0% | — | ||
39Annales de Toxicologie AnalytiqueElsevier BV · France | 0.12Q4 | 0.20 0.03 down from 2007 | 90 | 93% | $3,140 | ||
| 0.00Q4 | 0.00 0.06 down from 2007 | 78 | 100% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2008. Corpus-wide, 71.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
15 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2005–2007, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2008. Publication window: 2005–2007. How these summaries are calculated
- Ranked journals
- 40
- Window papers (baseline)
- 38,146 +30.8% from indicator year 2005
- Median OJR
- 0.9471 +13.9% from indicator year 2005
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2005–2007 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.